NK Cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT

The EBMT activity survey 2009: trends over the past 5 years

(2011) H Baldomero et al.   BONE MARROW TRANSPLANTATION

Reduced-intensity allogeneic stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantation

(2011) Ki Woong Sung et al.   PEDIATRIC BLOOD & CANCER

Dose-dense temozolomide regimens

(2010) Bart Neyns et al.   CANCER

High-Dose Iodine-131-Metaiodobenzylguanidine with Haploidentical Stem Cell Transplantation and Posttransplant Immunotherapy in Children with Relapsed/Refractory Neuroblastoma

(2009) Jacek Toporski et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

(2009) P Ljungman et al.   BONE MARROW TRANSPLANTATION

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

(2009) Katherine K. Matthay et al.   JOURNAL OF CLINICAL ONCOLOGY

28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures

(2008) R Ladenstein et al.   BONE MARROW TRANSPLANTATION

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

(2008) Cédric Ménard et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials

(2008) VF Viprey et al.   JOURNAL OF PATHOLOGY